Frontiers Effect of the serum 25-hydroxyvitamin D level on risk for short-term residual dizziness after successful repositioning in benign paroxysmal positional vertigo stratified by sex and onset age

ObjectiveA low serum 25-hydroxyvitamin D (25(OH)D) level is relevant to both the occurrence and recurrence of benign paroxysmal positional vertigo (BPPV). Ho

Nutrients, Free Full-Text

PDF) Clinical and cVEMP Evaluation Predict Short-Term Residual Dizziness After Successful Repositioning in Benign Paroxysmal Positional Vertigo

PDF) Low Antioxidant Status of Serum Uric Acid, Bilirubin, Albumin, and Creatinine in Patients With Benign Paroxysmal Positional Vertigo

vocab.txt · fspanda/electra-medical-discriminator at main

25 (OH) D3 levels, incidence and recurrence of different clinical forms of benig paroxysmal positional vertigo - ScienceDirect

PDF) Low Antioxidant Status of Serum Uric Acid, Bilirubin, Albumin, and Creatinine in Patients With Benign Paroxysmal Positional Vertigo

HODo risk groups predicting BPPV recurrence.

Audiology Research, Free Full-Text

2017 AAN Annual Meeting Science Program by American Academy of

Frontiers TGF-β based risk model to predict the prognosis and immune features in glioblastoma

25-hydroxyvitamin D, Fibroblast Growth Factor 23, and Risk of Acute Kidney Injury Over 20 Years of Follow-Up - ScienceDirect

PDF) Association Between Serum Uric Acid Levels and Benign Paroxysmal Positional Vertigo: A Systematic Review and Meta-Analysis of Observational Studies

Benign paroxysmal positional vertigo as a complication of 90-day head-down bed rest

Frontiers TGF-β based risk model to predict the prognosis and immune features in glioblastoma